Florian von der Muelbe
Founder at CureVac SE
Profile
Florian von der Muelbe is the founder of CureVac SE and CureVac NV, both founded in 2000.
He holds the title of Chief Production Officer at CureVac SE from 2018 to present.
He also held the title of Chief Production Officer at CureVac NV from 2015 to 2021.
Dr. von der Muelbe is currently a Co-Managing Director at CureVac Real Estate GmbH since 2017.
He previously worked as a Principal at Biotest AG.
Dr. von der Muelbe holds a doctorate from Eberhard Karls Universität Tübingen and an MBA from ESB Business School.
Florian von der Muelbe active positions
| Companies | Position | Start |
|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Founder | 1999-12-31 |
CureVac Real Estate GmbH
 CureVac Real Estate GmbH Real Estate DevelopmentFinance CureVac Real Estate GmbH manages commercial and non-residential buildings. The company is headquartered in Tuebingen, Germany. | Chief Executive Officer | 2017-01-31 |
Former positions of Florian von der Muelbe
| Companies | Position | End |
|---|---|---|
| CUREVAC N.V. | Founder | 2021-06-30 |
| BIOTEST AG | Corporate Officer/Principal | - |
Training of Florian von der Muelbe
| Eberhard Karls Universität Tübingen | Doctorate Degree |
| ESB Business School | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOTEST AG | Health Technology |
| CUREVAC N.V. | Health Technology |
| Private companies | 2 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
CureVac Real Estate GmbH
CureVac Real Estate GmbH Real Estate DevelopmentFinance CureVac Real Estate GmbH manages commercial and non-residential buildings. The company is headquartered in Tuebingen, Germany. | Finance |
- Stock Market
- Insiders
- Florian von der Muelbe